MingWeiK
2021-12-14

$Finch Therapeutics Group, Inc.(FNCH)$$Myovant Sciences Ltd.(MYOV)$MYOV Target of acquisition by Sumi who is facing patent cliff and already bought out 4 others “vant”companies. Besides, the fundamentals are strong here… 2 blockbuster drugs approved and commercialised by $Pfizer(PFE)$ with tiered payment for 4.2billion.. MYOV also holding cash in excess of 600millions with a market capital of $1.3billion. Definitelya good buyout at $30 minimum. Let’s take this opportunity to stand up against the giants who has been manupulating this and robbing the common investors like us.

Enterprise Value vs EBITA is 20x stronger than last quarter when the price is ard $30

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法